Voglibose tablet is an oral hypoglycemic drug, which belongs to α - glucosidase inhibitor. It can inhibit α - glycosidase in the intestinal tract. The main function of α - glycosidase can decompose carbohydrates, which is conducive to the absorption of the body. Voglibose inhibits the disaccharide hydrolase that decomposes disaccharides into monosaccharides in the intestinal tract, that is, it delays the digestion and absorption of sugar, thus improving the blood sugar of patients after meals. Therefore, this drug is mainly used for diabetic patients to reduce the blood sugar after meals. Usually, it is necessary to cooperate with diet therapy and exercise therapy to play a multi directional role in reducing blood sugar. In conclusion, Voglibose tablets are oral hypoglycemic drugs, mainly used to reduce postprandial blood sugar.
